InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Bios Equity COF, LP, Director. Officer active across 1 companies, notably Actuate Therapeutics, INC.. In total, 2 disclosures have been logged. Total volume traded: €855k. The latest transaction was disclosed on 27 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
US$427,63271,428 shares@ US$5.98690.68% mcap100.0% of flow
Common Stock
SEC:0001104659-25-063993·
Ideal exit: 24 Mar 2026 (T+270)
€427,63271,428 shares@ €5.98690.68% mcap50.0% of flow
Common Stock
SEC:0001104659-25-063993:0·
Ideal exit: 24 Mar 2026 (T+270)
2 of 2 declarations
About Bios Equity COF, LP
Bios Equity COF, LP is a Director at Actuate Therapeutics, Inc. As a board member, it contributes to the governance of the company and strategic decision-making. Its experience in the financial sector allows it to provide valuable insights.
